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SESSLER, F. M., S. M. GRADY, B. D. WATERHOUSE AND H. C. MOISES. Electrophysiological actions of VIP in rat 
somatosensory cortex. PEPTIDES 12(4) 715-721, 1991.--Electrophysiological and biochemical studies suggest that VIP may ex- 
ert a facilitating action in the neocortical local circuitry. In the present study, we examined the actions of VIP and VIP + norepi- 
nephrine (NE) on somatosensory cortical neuron responses to direct application of the putative transmitters acetylcholine (ACh) 
and gamma-aminobutyric acid (GABA). Spontaneous and transmitter-induced discharges of cortical neurons from halothane-anes- 
thetized rats were monitored before, during and after VIP, NE and VIP + NE iontophoresis. In 57 VIP-sensitive cells tested, VIP 
application (5-70 nA) increased (n= 18), decreased (n=36) or had biphasic actions (n=3) on background firing rate. In a group 
of 20 neurons tested for NE + VIP, the combined effect of both peptide and bioamine was predominantly (70%) inhibitory. On 
the other hand, inhibitory and excitatory responses of cortical neurons to GABA (11 of 15 cases) and ACh (10 of 18 cases), 
respectively, were enhanced during VIP iontophoresis. Concomitant application of VIP and NE produced additive (n = 2) or more 
than additive (n = 3) enhancing effects on GABA inhibition. NE administration reversed or enhanced further VIP modulatory ac- 
tions on ACh-induced excitation. These findings provide electrophysiological evidence that NE and VIP afferents may exert con- 
vergent influences on cortical neuronal responses to afferent synaptic inputs such that modulatory actions are anatomically focused 
within the cortex. 
Vasoactive intestinal polypeptide Norepinephrine GABA Cortex Acetylcholine Neuromodulation 
A number of findings suggest that vasoactive intestinal polypep- 
tide (VIP) may play a role in neuronal transmission within the 
cerebral cortex (26). VIP is found in high concentration in this 
area (13), and is located primarily in bipolar neurons oriented 
perpendicular to the pial surface (13,20). The peptide can be re- 
leased in a Ca + +-dependent manner from synaptosomal prepa- 
rations (8) and rat brain slices (2). VIP binding has been 
observed in cerebral cortex (29) and local application of VIP to 
individual cortical neurons produces both inhibitory and excit- 
atory responses (6, 9, 12, 24). Additional biochemical studies 
have shown that VIP can alone or by synergistic interaction with 
norepinephrine (NE) increase cycl ic-AMP (cAMP) levels in 
cerebrocortical tissue (15). 
VIP-containing neurons constitute an intracortical peptidergic 
system which is oriented perpendicular to the tangential trajec- 
tory of NE-containing axons emanating from cell bodies in the 
brainstem nucleus locus coeruleus. It has been suggested (18,20) 
that this unique anatomical arrangement may subserve a specific 
physiologic function whereby the potential heterosynaptic inter- 
action of NE-VIP input on common target neurons could create 
conditions leading to enhancement of cAMP-mediated events. 
As a fas t  step in assessing VIPergic influences on cerebrocorti- 
cal synaptic transmission, we examined the interaction between 
microiontophoretically applied VIP and somatosensory cortical 
neuron responses to locally applied putative neurotransmitters, 
gamma-aminobutyric acid (GABA) and acetylcholine (ACh). A 
second goal of the study was to evaluate the effects of simulta- 
neous application of NE and VIP on spontaneous and evoked 
cortical neuronal activity. 
The results indicate that VIP produces predominantly facili- 
tating effects on transmitter-induced responses of somatosensory 
cortical neurons. Simultaneous application of NE and VIP pro- 
duces either additive or more than additive facilitating effects on 
somatosensory cortical neuronal responsiveness to GABA appli- 
cation. By contrast, NE administration reverses or enhances VIP 
modulatory effects on ACh-induced excitation. A preliminary 
report of this work has appeared previously (32). 
METHOD 
Male Long-Evans hooded rats, 250-350 g, were anesthetized 
with halothane (0.8-1.5% in oxygen), intubated and allowed to 
breathe spontaneously. Animals were fixed in a stereotaxic ap- 
paratus and body temperature was maintained at 37°C with a 
heating lamp. Portions of the calvarium and dura were removed 
to obtain access to the somatosensory cortex. The exposed brain 
tissue was covered with 2% agar in balanced salt solution. 
The somatosensory cortex recording electrode was aimed: 
A - P = 0  to 2 mm; L = 3  to 5 mm, and 0 to 1.8 mm deep to pial 
surface (Paxinos et al., 1982). Five-barrel micropipets with 4-8  
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txm tips were used for drug application and single-unit record- 
ing. The center recording barrel of the pipet was filled with 4 M 
NaC1. One side barrel was filled with 3 M NaC1 and used for 
automatic current balancing. The remaining side barrels con- 
tained drug solution as follows: 0.5 M dl-norepinephrine HC1, 
pH 4.5 (Sigma); 0.5 M GABA, pH 3.8 (Sigma); I M acetyl- 
choline chloride, pH 4.5 (Sigma); 0.5-1 mM VIP (in 0.1 M 
NaC1 or distilled water), pH 5.5 (a gift of Dr. S. I. Said of the 
University of Oklahoma Health Sciences Center, Oklahoma 
City). Control procedures for assessing potential current artifacts 
and vehicle (NaC1) effects were carried out routinely. Extracel- 
lularly recorded action potentials were monitored using conven- 
tional methods. 
Regularly spaced iontophoretic pulses of GABA or ACh 
(10-20-s duration; 5-50 nA) were applied to individual cells un- 
til stable agonist responses were obtained. Perievent histograms 
were then collected before, during and after VIP or VIP + NE 
iontophoresis. Agonist ejection currents were selected to induce 
approximately 40-50% of the response maxima. Putative trans- 
mitter responses were quantitated by comparing the average dis- 
charge rate of the neuron during transmitter application with the 
mean firing rate between drug pulses and expressing the differ- 
ence as a percentage inhibition or excitation of baseline firing 
frequency. 
Drug interactions were frequently conducted using ionto- 
phoretic doses of VIP which were subthreshold for causing 
changes in the baseline fhing rate of recorded neurons. This 
procedure reduced the possibility that changes in cell responsive- 
ness observed during VIP administration were due simply to an 
algebraic summation of ongoing excitatory or inhibitory VIP ef- 
fects. All interactions between neurotransmitters were judged 
against criteria based on quantification of responses from histo- 
gram records (27,31). Changes in responses to excitatory or in- 
hibitory stimuli by VIP were assessed by comparing the discharge 
rate in identical epochs of baseline and drug-induced activity 
taken from control and VIP histograms. VIP was declared to 
have no significant differential effect on inhibitory or excitatory 
responses when the percentage of change in evoked versus 
spontaneous discharge was equivalent. A difference of at least 
15% between percent of VIP-induced changes in evoked versus 
spontaneous activity was established as the criterion for declar- 
ing a differential effect (i.e., "augmentation," "enhancement" 
or"antagonism") on evoked versus spontaneous discharge. "Aug- 
mentation" of an inhibitory response was declared when firing 
rate during the response epoch was depressed more by VIP ap- 
plication than was spontaneous discharge. Conversely, the inter- 
action was defined as "antagonistic" when spontaneous discharge 
was depressed more by VIP than activity occurring during the 
inhibitory response period. 
"Enhancement" of excitatory responses was declared when 
evoked spiking was increased above control levels relative to no 
change or suppression of background f'mng or when activity 
during evoked excitation was suppressed by VIP but to a lesser 
extent than was background firing. The interaction was termed 
"antagonistic" when the excitatory response was more sup- 
pressed than spontaneous firing during VIP iontophoresis. These 
criteria for quantitative evaluation of VIP interactions with neu- 
ronal responses to synaptic stimuli have been employed previ- 
ously to asses NE actions in cerebral cortex (30), cerebellum 
(19,28) and hypothalamus (4,27). 
RESULTS 
Of 140 neurons recorded from the somatosensory cortex, 65 
(46%) were sensitive to VIP application. The majority of these 
TABLE 1 
VIP AND VIP + NE EFFECTS ON SPONTANEOUS FIRING ACTIVITY OF 
SOMATOSENSORY CORTICAL NEURONS 
N Inhibition Biphasic Excitation 
VIP effects on 57 63% 5% 32% 
spontaneous activity (SA) 
NE effects on 
VIP-induced inhibition 




(or reversal) (or reversal) 
11 73% 27% 
9 67% 33% 
(n=56, 86%) were found in cortical layers between 700-1600 
t~m deep from the pial surface. VIP-induced changes in cortical 
unit responsiveness to ACh and GABA application were ob- 
served in cells within this same region. 
Effects of  VIP on Cortical Neuron Spontaneous Discharge 
Only spontaneously active VIP-responsive somatosensory cor- 
tical neurons (N= 57) were used in this study. Their frequency 
of discharge ranged from 0.5 to 26.7 Hz (mean=7.1 -+0.7 Hz; 
mean -+ SE). No significant relation could be established between 
cell depth, spontaneous firing frequency and response to VIP. 
In 36 of 57 cells exhibiting spontaneous discharge, continu- 
ous iontophoretic application of VIP (5-70 nA) reduced firing 
rate by 27.1-+3.2% (mean -+ SEM) from control. In 18 other 
cells, spontaneous activity was increased an average of 
42.5 -+ 10.1% during VIP application. In three remaining cells, 
VIP induced biphasic effects on baseline activity (see Table 1). 
The combined effects of NE + VIP application were exam- 
ined in 20 VIP-sensitive cells (9 excited and 11 inhibited by 
VIP). In 70% of these cases (n= 14), NE + VIP application 
produced depression of somatosensory cortical neuron discharge 
even though VIP alone evoked excitation in 6 of these cells. In 
most of these cases, NE was applied at doses that alone pro- 
duced little or no change in spontaneous f'n'ing. In 6 other cases, 
the combination of NE + VIP produced: 1) excitation like that 
observed with VIP alone (n = 3) or 2) reversal of VIP-induced 
suppression of spontaneous activity (n = 3) (see Table 1). 
Overall, these results show that VIP alone has facilitatory and 
inhibitory actions on background firing; however, the combined 
effect of NE + VIP is predominantly inhibitory. Thus, as pre- 
viously reported by Ferron et al. (6), NE can convert VIP exci- 
tation into inhibition. 
Effects of  VIP on Cortical Neuronal Responses to GABA 
Pulsatile applications of GABA (10-s duration, every 40 s) 
produced consistent decreases in somatosensory cortical cell dis- 
charge. Interactions between VIP and neuronal responses to mi- 
croiontophoretically applied GABA were analyzed in 15 cells. 
In the majority of the cases (n = I 1, 73%), inhibitory responses 
to GABA were ~ l y  enhanced during VIP iontophofesis 
(see Table 2). An example of this effect is shown in Fig. 1A. In 
this neuron, administration of the peptide (20 hA) produced a 
reduction in discharge rate during the GABA response period 
from 4.26 (control) to 1.42 (VIP) spikes/s, but little change in 
the background firing rate of the cell. This differential action of 
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FIG. 1. VIP-mediated enhancement of GABA-induced inhibition and interaction with NE-mediated 
augmentation of GABA inhibition of cortical neurons. Continuous ratemeter (top: A1,B1,C1) and 
histogram (bottom, A2,B2,C2) show the responses of a cortical neuron to iontophoretic pulses (30 
nA; every 40 s) of GABA (solid bars) before, during and after continuous microiontophoresis (bro- 
ken bars) application of: VIP 20 nA (A); NE 15 nA (B); and VIP 20 nA + NE 15 nA (C). Histo- 
grams sum activity during 5 consecutive GABA applications. (A2) Constant application of VIP 
markedly enhanced the GABA-mediated inhibition from -35% to -79%,  without affecting the 
background activity of the cell, yielding a 126% increase of the inhibition relative to control. (B2) 
Administration of NE 15 nA augmented the GABA-mediated inhibition from -49% to -63%, 
yielding a 28% increase of the inhibition relative to control. (C2) Simultaneous administration of VIP 
and NE augmented the GABA inhibition from -30% to -92%, yielding a 206% increase of the 
inhibition relative to control period. Calibration: vertical, 5 spikes; horizontal, 20 s (top), 10 s 
(bottom). 
VIP on transmitter-induced versus spontaneous activity yielded a 
125% enhancement (from 35% to 79%) of the GABA response 
relative to the control condition. Recovery to the control level 
of response was observed a few minutes after cessation of VIP 
administration. 
A summary of the results of similar quantitative analyses for 
all 15 neurons examined (open squares) is presented in Fig. 2. 
The majority (73%) of data points lie well above the 45 degree 
"equivalence"  line, indicating cases in which firing rate during 
the GABA-induced inhibitory period was depressed more during 
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TABLE 2 
VIP EFFECTS ON GABA- AND ACh-EVOKED NEURONAL RESPONSES 
No Differential 
N Antagonism Effect Facilitation 
VIP effects on 15 0% 27% 73% 
GABA-evoked inhibition 
VIP effects on 18 22% 22% 56% 
ACh-evoked excitation 
VIP iontophoresis than was spontaneous discharge. In 4 of 15 
cases (27%), spontaneous activity and discharge rate during the 
GABA response period were affected to an equivalent extent 
during VIP administration (points plotted closest to the 45 de- 
gree "equivalence" line). Overall, this distribution of points in- 
dicates a trend toward a VIPergic facilitation of GABA inhibitory 
action. 
Effects of  VIP on Cortical Neuronal Responses to ACh 
Pulsatile iontophoretic application of ACh (10-20-s duration, 
every 40-50 s) produced consistent increases in somatosensory 
cortical cell discharge as illustrated in Fig. 3. Interactions be- 
tween VIP and cortical neuronal responses to microiontophoreti- 
cally applied ACh were analyzed in 18 cells (see Table 2). In 
10 of these cells (56%), VIP application enhanced ACh-induced 
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FIG. 2. Graphic summary of ~ potentiating effects on GABA-mcdi- 
ated inhibition of somatosensory cortical neurons. Each plotted point in- 
dicates the VIP-indueed change in GABA-mediated (open square) inhibition 
versus spontaneous discharge for one cortical neuron as determined from 
quantitative analysis of drug response perievent histograms. The dotted 
45 degree line indicates the prediction of an equivalent effect of VII' on 
spon taneous  ac t iv i ty  and  f i r ing rate  dur ing  the inhibi tory  response  pc .  
rio& Data points lying above the "equivalence line" represent cases 
where GABA-induced inhibition was augmented relative to changes in 
background fLring. 
neuron whose responses to ACh administration were increased 
above control levels during an iontophoretic dose of VIP (30-50 
nA) which caused little change in the background activity of the 
cell. Quantitative assessment of the VIP-induced changes in 
evoked versus spontaneous firing frequency revealed an absolute 
increase (38%) in the ACh response from 8.2 (control) to 11.3 
(VIP) spikes/s, whereas spontaneous activity was decreased from 
1.1 (control) to 0.9 (VIP) spikes/s. Recovery was observed a few 
minutes after cessation of VIP iontophoresis. 
In 4 cells, ACh-induced excitation was antagonized during 
local administration of VIP, and in 4 other cases spontaneous 
and ACh-evoked discharge were equally affected by VIP, yield- 
ing no net differential change in cholinergic response (see 
Table 2). 
VIP + NE Effects on Cortical Neuronal Responses to 
ACh and GABA 
The effects of VIP + NE on cortical neuronal responses to 
GABA (n=6)  or ACh (n=  14) were examined in 20 cells. Si- 
multaneous application of VIP and NE enhanced GABA-induced 
inhibition in 5 of 6 cells tested. In 2 of these cases, VIP + 
NE-mediated augmentation of GABA responses was equivalent 
to algebraic summation of the actions of VIP and NE alone on 
GABA responses. In the 3 other neurons tested, the resulting 
augmentation was equivalent to a more than additive effect of 
the monoamine and peptide on GABA depressant actions (see 
Table 3). Figure 1 illustrates one such case where VIP alone, 
NE alone and VIP + NE produced 125% (from 35% to 79%), 
28% (from 49% to 63%) and 206% (from 30% to 92%) aug- 
mentation of GABA responses, respectively. 
By contrast, continuous iontophoretic administration of VIP 
+ NE during pulsatile ACh application (n=  14) produced var- 
ied effects which were not predictable on the basis of an alge- 
braic summation of the actions of NE and VIP alone on ACh- 
induced excitation. For example, Fig. 4 illustrates a case where 
VIP alone and NE alone produced 156% (41% to 105%) and 
122% (from 37% to 82%) increases in ACh-evoked responses, 
respectively. However, in the same cell simultaneous application 
of VIP + NE produced a 41% (from 37% to 22%) reduction in 
ACh-induced excitation relative to background fLring (see 
Table 3). 
Overall, we observed that NE application further augmented 
VIP-mediated enhancement of GABA-induced suppression of 
cortical cell discharge, yet VIP actions on ACh-induced excita- 
tion were either enhanced or reversed by NE administration. 
DISCUSSION 
Although the anatomic organization of VIP-containing neu- 
rons in the neocortex has been well studied (16, 17, 21), the 
effects of VIP on cortical neuron excitability have not yet been 
examined in great detail. In this study, we employed several ex- 
perimental strategies to characterize the effects of VIP on neu- 
ronal responsiveness within the rat somatosensory cortex. 
Iontophoretic application of VIP produced both excitatory and 
inhibitory effects on the fu'ing rate of spontaneously active corti- 
cal neurons. The direction of these effects was independent of 
cortical depth and spontaneous fLring frequency of the neurons 
tested. Concomitant application of NE increased VIP's inhibi- 
tory action or, conversely, reversed VIP's excitatory effect on 
spontaneous discharge. Synergistic interactions between this mono- 
amine and VII' have been reported previously by Ferron et al. 
(6). In addition, low doses of iontophoretically applied VIP were 
capable of modulating both excitatory and inhibitory responses 
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FIG. 3. VIP enhancement of ACh-induced excitation. Continuous ratemeter (top) and corresponding his- 
togram (bottom) (sum of 4 ACh applications) records illustrate the response of a somatosensory cortical 
neuron to iontophoretic pulses (50 nA; every 40 s) of ACh before, during and after continuous microion- 
tophoretic application of VIP (30-50 nA). VIP administration increased the ACh-induced excitation by 
72%, from 646% to 1116%. Calibration: Horizontal, 10 s; vertical, 10 (top), 5 (bottom) spikes. 
of somatosensory cortical neurons to iontophoretic application of 
ACh and GABA, respectively. We also observed that NE in 
combination with VIP could enhance peptide-induced changes in 
neuronal excitability. 
It is worth noting that many cells responding to VIP in the 
present study were located in deep cortical layers (700-1600 
p,m). VIP-responsive cells have been identified by others as py- 
ramidal neurons (6, 12, 24). Such cells have long apical den- 
drites which extend from layer V or III to layer I and thus are 
well positioned to receive convergent synaptic inputs from VIP- 
ergic and noradrenergic afferents (18). In addition, because of 
this unique arrangement (13, 18, 20, 21), VIP-containing neu- 
rons and NE-contalning cortical afferents may directly influence 
and modulate the cortico-cortical and corticofugal outputs from 
targeted regions of the cortex. 
VIP Enhancement of  Cortical Neuronal Responses to GABA 
The results presented here demonstrate that iontophoretically 
applied VIP can facilitate GABA-induced suppression of cortical 
neuronal discharge. An important characteristic of this potentiat- 
ing action is that this effect does not appear to result from a 
simple summation of hyperpolarizing influences. As shown in 
Fig. 1, changes in neuronal responsiveness to GABA were ob- 
served at ejection currents of VIP that had little direct effect on 
spontaneous discharge. Thus amplification of GABA responses 
by VIP can occur independently of direct inhibitory effects on 
spontaneous firing mechanisms. We have recently observed in 
pilot experiments that iontophoretically applied VIP can also po- 
tentiate (7 of 8 cases) responses of cortical cells to synaptically 
mediated inhibition. 
In terms of what is known of VIP's cellular actions, it seems 
reasonable to suggest a link between the potentiating effect of 
VIP on inhibitory neuronal responses and its ability to stimulate 
intracellular production of cAMP. VIP has been shown to acti- 
vate adenylate cyclase in each of the tissues that possess high- 
affinity VIP receptors (23,26). Furthermore, cyclic AMP-mediated 
phosphorylation of a subunit of the GABA-A receptor has been 
proposed as a possible means of regulating the efficacy of 
GABA at central synapses (11). In this regard, VIP effects on 
GABA-induced neuronal responses are similar to those observed 
with other agents which elevate intracellular levels of cyclic 
AMP such as isoproterenol (beta agonist), 8-bromo cyclic AMP 
(membrane permeant analog of cyclic AMP), forskolin (direct 
activator of adenyl cyclase) and IBMX (phosphodiesterase inhib- 
itor) (28). 
TABLE 3 
vIP + NE EFFECTS ON GABA- AND ACh-INDUCED NEURON RESPONSES 
Facilitation Antagonism 
More Than More Than 
N Additive Additive Additive Additive 
VIP + NE effects on 
GABA-induced inhibition 6 50% 
ACh-induced excitation 14 29% 
33% 17% 0% 
0% 64% 7% 
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FIG. 4. VIP-mediated enhancement of ACh-induced excitation and interaction with NE-mediated 
augmentation of ACh excitation of cortical neurons. Histograms sum activity during 5 consecutive 
ACh (40 nA) applications. (a,b) Constant application of VIP (25 nA) markedly enhanced the ACh- 
mediated excitation from 41% to 105% by suppressing more the background discharges than the 
evoked activity (enhancement of signal to noise ratio). This action of VIP yielded a 156% increase 
of the excitation relative to control. (c,d) Administration of NE (I0 nA) augmented the ACh-medi- 
ated excitation from 37% to 82%, yielding a 122% increase of the response relative to control 
period. (e,f) Simultaneous administration of VIP and NE antagonized the ACh excitation from 37% 
to 22%, yielding a 41% decrease in ACh response. Calibration: vertical, 5 spikes; horizontal, 15 s. 
When VIP and NE were applied simultaneously, they pro- 
duced additive and in some cases more than additive enhance- 
ment of GABA-evoked inhibition. These alterations in GABA- 
responsiveness may be related to a combined action of VIP and 
NE affecting intracellular levels of cAMP. For example, the in- 
teraction between VIP and other drugs known to stimulate pro- 
duction of cAMP (e.g., dopamine, norepinephrine, isoproterenol, 
prostaglandin E l ,  adenosine) can produce additive (25) and in 
some case more than additive (15) increases of cAMP in brain 
tissue (25). 
VIP Modulation of Cortical Neuronal Excitatory Responses 
Iontophoretically applied VIP produced predominantly facili- 
tatory (56%) and in some cases antagonistic (22%) effects on 
ACh-evoked discharges of cortical neurons. Results from other 
studies have shown that such VIPergic influences on ACh- 
evoked responses are specific for cholinergic mechanisms (12). 
More recent experimental evidence suggests that VIP may 
also exert its facilitating action on ACh-induced excitation through 
a cAMP-dependent intracellular mechanism. In the hippocampus 
(14) and neocortex (7), intraceUular increase of cAMP, or direct 
application of a membrane permeant analog of cAMP (14) has 
been shown to block accommodation of pyramidal cell dis- 
charge, thus resulting in a net increase in neuronal response to 
depolarizing stimuli. Since mechanisms responsible for blockade 
of accommodation are also sensitive to ACh (22), they could be 
a target for converging VIP + ACh influences on neuronal ex- 
citability. 
The likelihood of a physiologically relevant VIP-ACh inter- 
action is further supported by a report describing an intracortical 
cholinergic system with the same morphological characteristics 
as VIP neurons (5). Over 80% of the choline acetyltransferase 
(ChAT)-positive neurons described in that study also contained 
VIP. The fact that chronic atropine treatment causes a 75% in- 
crease in VIP receptors in cerebral cortex (1) also suggests a 
functional VIP-ACh interaction. 
In many cases, application of NE potentiated VIP's actions 
on ACh-evoked excitatory responses. These effects were ob- 
served even if NE and VIP alone had opposite actions on 
cholinergic responses. In other cases, NE application antago- 
nized VIP's effects on ACh responses. This antagonistic interac- 
tion was observed even when application of NE or VIP alone 
had facilitating effects on ACh responses (Fig, 4). While the 
present studies made no attempt to identify the mechanisms re- 
sponsible for these mixed effects, the data suggest a unique 
mode of modulatory interaction between monoamine and pep- 
tide in cortical circuits. 
In summary, these findings provide electrophysiological evi- 
dence that VIP can alter inhibitory and excitatory somatosensory 
cortical neuronal responses to iontophoretically applied putative 
transmitters. This action of VIP could be of importance in un- 
derstanding the precise function of this neuropeptide in cortical 
circuits and its involvement in various pathological conditions 
(3,10). Our observations further suggest that VIP and NE can 
act together to alter the efficacy of local excitatory and inhibi- 
tory inputs to neocortical neurons. These f'mdings support the 
hypothesis that the essentially perpendicular orientation of NE 
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fibers and VIPergic neurons in the cerebral cortex may subserve 
a precise physiological function (15,18). Specifically, NE and 
VIP afferents may exert convergent influences on cortical neu- 
ronal responses to afferent synaptic inputs such that modulatory 
actions are anatomically focused within the cortex. VIP neurons 
could then be part of a local mechanism whose function would 
be to regulate an otherwise global effect of NE on signal pro- 
cessing within neocortical circuits. 
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